http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016073825-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bab51dbb81468c1c6978289aacc6d60a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d89750417cfc574c6fec23727f3b859c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326fe70d24bbfd05ccb5832da9ad1693
publicationDate 2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016073825-A1
titleOfInvention Dosage regimen for pegylated interferon
abstract A pegylated type I interferon for use in treating an infectious disease, cancer, or myeloproliferative disease in a subject in need thereof, wherein a 50 to 540 μg dose of the pegylated type I interferon is administered to the subject at a regular interval for a treatment period, the interval being 3 to 8 weeks.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018134260-A1
priorityDate 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5738846-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5382657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010014874-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012310140-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009023826-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542

Total number of triples: 32.